Results 141 to 150 of about 199,968 (239)
Worku Mekonnen Sefefe,1 Destaw Biadgie Tesfaw,2 Andualem Dagne Tebikew,2 Assefa Sisay Ayenew,3 Bereket Amare Dencha,4 Temesgen Agegnehu Abebe1 1Department of Surgery, Debre Markos University (DMU), Debre Markos, Amhara, Ethiopia; 2Department of Surgery ...
Sefefe WM +5 more
doaj
Recent Development of Endo‐hepatology
ABSTRACT Endo‐hepatology is a rapidly evolving field encompassing endoscopic diagnosis and treatment of hepatobiliary diseases, primarily using endoscopic ultrasound (EUS). Since its conceptualization in 2012, the field has expanded dramatically alongside advances in interventional EUS. A landmark 2024 review broadened the concept to include endoscopic
Akira Yamamiya +3 more
wiley +1 more source
The combined single‐cell and functional analysis depicts that miR‐941 targets CLDN4 and activates the regulatory axis that drives the malignancy of thyroid cancer through the PI3K/AKT pathway. Abstract Claudin‐4 (CLDN4), a key tight junction protein, has been implicated in tumor progression; however, its functional role and regulatory mechanisms in ...
Jinghua Zhou +9 more
wiley +1 more source
Sex‐stratified analyses of the TCGA and CGGA cohorts have identified promoter‐proximal TACSTD2 CpG sites where methylation shows opposite survival associations in males and females, is independent of copy number, and correlates with TACSTD2 expression.
Tahreem Fatima
wiley +1 more source
ABSTRACT Aims Incretin‐based pharmacotherapy was initially developed to improve glucose‐dependent insulin secretion and glycaemic control in type 2 diabetes, but its clinical interpretation has expanded substantially with cardiovascular outcome trials, kidney outcome data, obesity studies and next‐generation polyagonist development.
Ferenc Sztanek +3 more
wiley +1 more source
Analysis of CT and MRI imaging features of ectopic pancreas. [PDF]
Chen SM, Chen GW.
europepmc +1 more source
ABSTRACT Background Individually, sodium–glucose co‐transporter‐2 inhibitors (SGLT2i) and glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) have been shown to reduce major kidney and cardiovascular events in patients with chronic kidney disease (CKD). However, evidence supporting combined GLP‐1RA and SGLT2i therapy in this population remains limited.
Hussain Salim +9 more
wiley +1 more source
IGF2BP1 promotes gemcitabine resistance in pancreatic cancer by stabilizing m6A‐modified FTH1 transcripts and protecting them in stress granules, thereby suppressing ferroptosis. Pharmacological inhibition of IGF2BP1 disrupts this protective pathway, restores ferroptotic sensitivity, and enhances gemcitabine efficacy in resistant tumors.
Ying‐Qin Zhu +10 more
wiley +1 more source
Gastric Ectopic Pancreas With Pseudocyst Formation Causing Gastric Outlet Obstruction. [PDF]
Dickerson A +6 more
europepmc +1 more source
Gastric Ectopic Pancreas: A Pediatric Case Report. [PDF]
Chemlal I, Hamami A, Rkain M.
europepmc +1 more source

